Form 4: Pacific Biosciences Executive Sells Shares to Cover Tax Obligations

Mark Van Oene, Chief Operating Officer of Pacific Biosciences, sold 38,011 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 16, 2024, Mark Van Oene, the Chief Operating Officer of Pacific Biosciences, sold 38,011 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price ranging from $1.64 to $1.69 per share, with an average price of $1.662.
• Following the transaction, Van Oene directly owns 1,630,815 shares of Pacific Biosciences common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes on vested stock). It's neutral in sentiment as it doesn't reflect positively or negatively on the company's performance or outlook.

Industry Context

Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of the executive's sentiment about the company's future prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact due to the routine nature of the transaction.

Key Dates